ST Pharm Co.,Ltd.
237690.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
205
Cost of Revenue
133
Gross Profit
72
Gross Margin
35.1%
Operating Income
21
Operating Margin
10.1%
Net Income
26
Net Margin
12.7%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
57
EBITDA Margin
27.8%
2023
12/31/2023
Revenue
214
Cost of Revenue
134
Gross Profit
80
Gross Margin
37.4%
Operating Income
23
Operating Margin
10.9%
Net Income
15
Net Margin
6.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
39
EBITDA Margin
18.4%
2022
12/31/2022
Revenue
187
Cost of Revenue
125
Gross Profit
62
Gross Margin
33.4%
Operating Income
13
Operating Margin
7.2%
Net Income
14
Net Margin
7.2%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
30
EBITDA Margin
15.9%
2021
12/31/2021
Revenue
124
Cost of Revenue
84
Gross Profit
40
Gross Margin
32.5%
Operating Income
4
Operating Margin
3.4%
Net Income
2
Net Margin
2.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
16
EBITDA Margin
12.6%
2020
12/31/2020
Revenue
93
Cost of Revenue
81
Gross Profit
12
Gross Margin
13.3%
Operating Income
-14
Operating Margin
-15.2%
Net Income
-9
Net Margin
-9.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-2
EBITDA Margin
-1.7%